UBS lowered the firm’s price target on Dentsply Sirona (XRAY) to $25 from $27 and keeps a Buy rating on the shares.
Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XRAY:
- Dentsply Sirona’s Q1 2025 Financial Performance Overview
- DENTSPLY SIRONA: Strong Earnings Overshadowed by Leadership Changes and Market Uncertainties
- DENTSPLY SIRONA: Hold Rating Amid Stabilizing Growth and Macro Challenges
- Dentsply Sirona’s Earnings Call: Growth Amid Challenges
- Cautious Optimism for DENTSPLY SIRONA Amid Recovery and Challenges: Hold Rating Maintained with Price Target at $17